2017-05-17 15:46:56 UTC

AGA-Pfizer Young Investigator Pilot Research Award in Inflammatory Bowel Disease

Application Deadline: Jan. 12, 2018
Start Date: July 1, 2018

Total Award Amount: $30,000
Term: 1 year
Number of Awards: 3
Eligible Categories: Career Development, Established Investigators

DESCRIPTION

This award provides $30,000 for one year to recipients at any career stage researching new directions focused on improving the diagnosis and treatment of inflammatory bowel disease (IBD).

 

OBJECTIVE

The objective of this pilot research award is to provide funds for early career investigators to help establish their research careers or to support projects that represent new research directions for established investigators.  Projects must focus on new research areas that could improve the diagnosis and treatment of IBD.

 

ELIGIBILITY

  • Candidates for this award must hold an MD, PhD, or equivalent degree (e.g., MBChB, MBBS, DO) and a full-time faculty position at an accredited North American institution.
  • AGA membership is required at the time of application submission. Please visit www.gastro.org or call 301-654-2055, extension 651, for membership information.
  • Women and minorities are strongly encouraged to apply.

 

REQUIREMENTS

  • The proposed research must focus on new research areas that could improve the diagnosis and treatment of IBD.
  • Applicants may not submit the same proposal to multiple AGA pilot awards offered in the same year.
  • Allowable Costs:
  • Funds may be used to support the salary and benefits of the primary investigator;
  • research assistants;
  • biostatistics support;
  • laboratory technicians;
  • supplies and/or equipment.
  • Unallowable Costs:
  • Indirect costs; and
  • Travel costs are not allowed.
  • Early career investigators are required to have a preceptor for this award. A preceptor will supervise the principal investigator’s research activities and will serve as a mentor.
    • MD applicants are considered “early career” if no more than seven years have elapsed following the completion of clinical training (GI fellowship or its equivalent) and the start date of this award.
    • PhD applicants are considered “early career” if no more than seven years have elapsed following the awarding of the PhD degree and the start date of this award.
  • Established investigators who are applying for this award should state explicitly how the research being proposed is different from their previous line of research.
  • The application must indicate how the investigators will use the pilot data for an extension of their work by applying to another agency (such as NIH).
  • Upon notification of receipt of this award, the recipient must provide approval from the appropriate institution committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation.
  • A scientific and financial progress report must be submitted to the AGA upon completion of the project and as needed upon request.

 

AWARD OVERLAP

At the time of application submission, candidates may not hold awards directly related to the proposed research from other organizations (i.e., government agency, foundation, academic institution, professional society, etc.).  If the candidate is granted the award and notified of a comparable award from another agency prior to the first payment of this award, the recipient must select one of the two awards (i.e., the recipient may not retain both awards).

 

SELECTION CRITERIA

The recipient will be selected based on the following criteria: significance, investigator, innovation, approach, environment, relevance to AGA’s mission, evidence of institutional commitment, and the overall likelihood that the project will lead to subsequent, more substantial grants.

 

REVIEW PROCESS

A selection committee comprising members of the AGA Research Awards Panel will review the proposals and select the award recipients. Funding will commence July 2018.

 

APPLICATION PROCESS

The application deadline is Jan. 12, 2018. Applications must be submitted through the AGA Grants Management System, accessible at http://www.gastro.org/research-funding. Application materials will not be accepted via mail, fax, or email. Select the “Apply Now” button to create an account and/or submit an application. Please direct all questions to the AGA Awards Program at awards@gastro.org.

 

For more information about this award and other research funding opportunities, visit the AGA website at http://www.gastro.org/research-funding .

 

Funding for this award is provided by Pfizer Inc.

More on IBD

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders and get inspired to improve patient care.

Treating HCV in Incarcerated Populations Key to Disease Elimination

Aug. 17, 2017

Infection rates range from 9.6% to 41.1%

IBD in the ED

Aug. 17, 2017

Emergency visits are a costly component of IBD care, but these factors can help ward off flares with dire complications